Speakers

Gregg Nyberg

Chief Technology Officer • Landmark Bio

Gregg Nyberg, Ph.D., brings more than 20 years’ biopharmaceutical industry experience to his new role at Landmark Bio. Most recently, he was associate vice president at Merck, where he led the company’s biologics process development and clinical manufacturing organizations. He also spent nearly 15 years in positions of increasing responsibility at Amgen including key leadership roles in process development and cell sciences and technology.

Dr. Nyberg earned a Ph.D. in chemical engineering from the Massachusetts Institute of Technology and a B.S. in chemical engineering and petroleum refining from the Colorado School of Mines.

Also Speaking

Matthew Hewitt

Executive Director, Scientific Services, Cell & Gene Therapy (CGT) • Charles River

Yossi Schwartz

Professor, Pathology, Molecular and Cell Based Medicine at the Icahn School of Medicine • Mount Sinai Health System

Tay Salimullah

Vice President, Head of Global Value & Access, Novartis Gene Therapies  • Novartis

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.